Citations

Clear

4 citation(s) found for "Chan, Mark".

Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program
Sun, N , Carr, Allison R. , Krogman, Erica N., Chawla, Yogesh , Zhong, Jun , Guttormson, Matthew C. , Chan, Mark , Hsu, Michelle A. , Dong, Haidong , Patel, Roosheel S. , Pandey, Akhilesh , Rogers, Laura M. , Ting, Adrian T. , Sun, Nicholas D , Bogunovic, Dusan , Pandey, Akhilesh , Dong, Haidong , Ting, Adrian T , Zhong, Jun , Rogers, Laura M , Chawla, Yogesh

Mayo Clinic

Science Signaling | July 7, 2026 | Volume: 19 | Issue: 945 | Pages: No page available

10.1126/scisignal.adz7366 | PMID 42412915 Get It

Cytotoxic T cells produce the cytokine interferon-γ (IFN-γ). We sought to determine whether IFN-γ directly kills target cells and found that T cells used IFN-γ to kill murine melanoma cells lacking the kinases TBK1 and IKKε. In the absence of both kinases, IFN-γ induced the production of TNF receptor 1 (TNFR1) and the sensor Z-DNA binding protein 1 (ZBP1) in the tumor cells to stimulate receptor-interacting protein kinase 1 (RIPK1)–dependent apoptosis in a cell-autonomous manner. IFN-γ also enhanced the activation of nuclear factor κB (NF-κB) signaling in a TNFR1-dependent manner in cells deficient in both TBK1 and IKKε. Because IFN-γ–induced apoptosis occurred in a transcription-dependent manner with slow kinetics, STAT1 and NF-κB cooperated to activate the expression of inflammatory genes in the dying cells. Thus, IFN-γ–induced cell death was accompanied by an inflammatory signature in the absence of TBK1 and IKKε. TBK1 and IKKε not only mediated the induction of type I IFN but also inhibited RIPK1-dependent death and NF-κB–dependent inflammation. Therefore, we propose that these kinases may have gained these intertwined functions so that cells infected by pathogens that produce antagonists of TBK1 and IKKε are eliminated by IFN-γ–secreting T cells in an inflammatory manner to compensate for the inhibition of type I IFN production.
Minimally invasive myocardial infarction model recapitulates patient immune responses and reveals a pathogenic role for immature neutrophils
Möller-Ramon, Zoe , Kaltenbach, Anna Christina, Puhl, Sarah‐Lena , Kwok, Immanuel , Sicklinger, Florian, Jansen, Yvonne , Ernst, Annick, Nitz, Katrin , Schloss, Maximilian J. , Leuschner, Florian , Chan, Mark Yan Yee , Weber, Christian, Nitz, Katrin , Kaltenbach, Anna Cristina , Sicklinger, Florian , Weber, Christian , Steffens, Sabine , Duchêne, Johan

Mayo Clinic

No container title available | March 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.05.709757 Get It

Abstract Myocardial infarction (MI) triggers a systemic neutrophil response, yet the roles of distinct neutrophil subsets in cardiac remodeling remain unclear. Studying this requires murine models that accurately mirror human neutrophil dynamics. Here, we show that a minimally invasive intact-chest MI model is more pathophysiologically relevant than the standard open-chest approach for investigating post-MI immune responses. In the open-chest model, surgical trauma disrupts bone marrow homeostasis, releases large numbers of immature neutrophils, and masks MI-specific immune mechanisms. In contrast, the intact-chest model preserves bone marrow integrity and induces only a modest rise in circulating immature neutrophils, closely reflecting MI patient profiles. We further demonstrate that accumulation of immature neutrophils in the infarcted heart exacerbates cardiac dysfunction. Beyond neutrophils, the overall cardiac immune landscape differs markedly between both models. Collectively, our findings establish the intact-chest model as superior for studying post-MI inflammation and reveal immature neutrophils as mediators of adverse cardiac remodeling.
Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death
Ang, Rosalind L. , Chan, Mark , Legarda, Diana , Sun, Shao‐Cong , Gillespie, Virginia , Chun, Nicholas , Heeger, Peter S. , Lira, Sérgio A. , Ting, Adrian T. , Sun, Shao-Cong , Chun, Nicholas , Heeger, Peter S , Xiong, Huabao , Ting, Adrian T , Sundberg, John P.

Mayo Clinic

Proceedings of the National Academy of Sciences | December 9, 2021 | Volume: 118 | Issue: 50 | Pages: No page available

10.1073/pnas.2001602118 | PMID 34887354 Get It

Significance The mechanisms underlying inflammatory disorders are poorly understood. In this study, we show that inappropriate cell death may cause uncontrolled inflammation. We found that CYLD, an enzyme that removes K63-linked polyubiquitination, is normally inhibited. But in the cpdm mouse strain that has a loss-of-function in the Sharpin gene, the brake on CYLD is no longer present. When CYLD is no longer inhibited, it turns on death signaling in cells exposed to the cytokine TNF, and the ensuing inappropriate cell death causes skin inflammation and other immune disorders in the cpdm mouse. Removing CYLD from the cpdm mouse prevents cell death and reverses the inflammation. We conclude that excessive CYLD activity leads to inappropriate cell death and inflammation.
T cell–derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death
Chun, Nicholas , Ang, Rosalind L. , Chan, Mark , Horwitz, Julian K. , Gelles, Jesse D. , Chipuk, Jerry E. , Kelliher, Michelle A. , Pavlov, Vasile I., Li, Yansui , Homann, Dirk , Ting, Adrian T. , Chun, Nicholas , Fairchild, Robert L. , Baldwin, William M. , Heeger, Peter S.

Mayo Clinic

JCI Insight | November 9, 2021 | Volume: 6 | Issue: 24 | Pages: No page available

10.1172/jci.insight.148643 | PMID 34752416 Get It

TNF ligation of TNF receptor 1 (TNFR1) promotes either inflammation and cell survival by (a) inhibiting RIPK1’s death-signaling function and activating NF- κ B or (b) causing RIPK1 to associate with the death-inducing signaling complex to initiate apoptosis or necroptosis. The cellular source of TNF that results in RIPK1-dependent cell death remains unclear. To address this, we employed in vitro systems and murine models of T cell–dependent transplant or tumor rejection in which target cell susceptibility to RIPK1-dependent cell death could be genetically altered. We show that TNF released by T cells is necessary and sufficient to activate RIPK1-dependent cell death in target cells and thereby mediate target cell cytolysis independently of T cell frequency. Activation of the RIPK1-dependent cell death program in target cells by T cell–derived TNF accelerates murine cardiac allograft rejection and synergizes with anti-PD1 administration to destroy checkpoint blockade–resistant murine melanoma. Together, the findings uncover a distinct immunological role for TNF released by cytotoxic effector T cells following cognate interactions with their antigenic targets. Manipulating T cell TNF and/or target cell susceptibility to RIPK1-dependent cell death can be exploited to either mitigate or augment T cell–dependent destruction of allografts and malignancies to improve outcomes.